IL103932A - Fatty acid and pharmaceutical compositions containing them - Google Patents

Fatty acid and pharmaceutical compositions containing them

Info

Publication number
IL103932A
IL103932A IL10393292A IL10393292A IL103932A IL 103932 A IL103932 A IL 103932A IL 10393292 A IL10393292 A IL 10393292A IL 10393292 A IL10393292 A IL 10393292A IL 103932 A IL103932 A IL 103932A
Authority
IL
Israel
Prior art keywords
fatty acid
pharmaceutical compositions
compositions containing
pharmaceutical
fatty
Prior art date
Application number
IL10393292A
Other languages
English (en)
Other versions
IL103932A0 (en
Inventor
Raphael Mechoulam
Villiam S Devane
Original Assignee
Yissum Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res & Dev filed Critical Yissum Res & Dev
Priority to IL10393292A priority Critical patent/IL103932A/xx
Publication of IL103932A0 publication Critical patent/IL103932A0/xx
Priority to CZ951361A priority patent/CZ136195A3/cs
Priority to US08/446,706 priority patent/US5618955A/en
Priority to JP6513466A priority patent/JPH08504195A/ja
Priority to PCT/US1993/011625 priority patent/WO1994012466A1/en
Priority to PL93309051A priority patent/PL309051A1/xx
Priority to EP94903364A priority patent/EP0670826B1/en
Priority to SK708-95A priority patent/SK70895A3/sk
Priority to CN93121715A priority patent/CN1097735A/zh
Priority to DE69328492T priority patent/DE69328492T2/de
Priority to ZA938947A priority patent/ZA938947B/xx
Priority to ES94903364T priority patent/ES2145118T3/es
Priority to HU9501561A priority patent/HUT73177A/hu
Priority to AU57334/94A priority patent/AU5733494A/en
Publication of IL103932A publication Critical patent/IL103932A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10393292A 1992-11-30 1992-11-30 Fatty acid and pharmaceutical compositions containing them IL103932A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IL10393292A IL103932A (en) 1992-11-30 1992-11-30 Fatty acid and pharmaceutical compositions containing them
AU57334/94A AU5733494A (en) 1992-11-30 1993-11-30 Fatty acid derivatives and pharmaceutical compositions containing them
EP94903364A EP0670826B1 (en) 1992-11-30 1993-11-30 Fatty acid derivatives and pharmaceutical compositions containing them
CN93121715A CN1097735A (zh) 1992-11-30 1993-11-30 脂肪酸衍生物和含有脂肪酸衍生物的药物组合物
JP6513466A JPH08504195A (ja) 1992-11-30 1993-11-30 脂肪酸誘導体及びこれを含有する医薬組成物
PCT/US1993/011625 WO1994012466A1 (en) 1992-11-30 1993-11-30 Fatty acid derivatives and pharmaceutical compositions containing them
PL93309051A PL309051A1 (en) 1992-11-30 1993-11-30 Novel pure polyunsaturated fatty acid amides and their derivatives
CZ951361A CZ136195A3 (en) 1992-11-30 1993-11-30 Derivatives of fatty acids and pharmaceutical compositions containing thereof
SK708-95A SK70895A3 (en) 1992-11-30 1993-11-30 Fatty acid derivatives and pharmaceutical compositions containing them
US08/446,706 US5618955A (en) 1992-11-30 1993-11-30 Fatty acid derivatives and pharmaceutical compositions containing same
DE69328492T DE69328492T2 (de) 1992-11-30 1993-11-30 Fettsäure-derivate und diese enthaltende pharmazeutische präparationen
ZA938947A ZA938947B (en) 1992-11-30 1993-11-30 Fatty acid derivatives and pharmaceutical compositions containing them
ES94903364T ES2145118T3 (es) 1992-11-30 1993-11-30 Derivados de acidos grasos y composiciones farmaceuticas que los contienen.
HU9501561A HUT73177A (en) 1992-11-30 1993-11-30 Fatty acid derivatives and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10393292A IL103932A (en) 1992-11-30 1992-11-30 Fatty acid and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
IL103932A0 IL103932A0 (en) 1993-04-04
IL103932A true IL103932A (en) 1997-02-18

Family

ID=11064282

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10393292A IL103932A (en) 1992-11-30 1992-11-30 Fatty acid and pharmaceutical compositions containing them

Country Status (13)

Country Link
EP (1) EP0670826B1 (zh)
JP (1) JPH08504195A (zh)
CN (1) CN1097735A (zh)
AU (1) AU5733494A (zh)
CZ (1) CZ136195A3 (zh)
DE (1) DE69328492T2 (zh)
ES (1) ES2145118T3 (zh)
HU (1) HUT73177A (zh)
IL (1) IL103932A (zh)
PL (1) PL309051A1 (zh)
SK (1) SK70895A3 (zh)
WO (1) WO1994012466A1 (zh)
ZA (1) ZA938947B (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0777415A4 (en) * 1994-07-11 1999-06-16 David W Pate COMPOSITIONS CONTAINING AN ANANDAMIDE ANALOG AND METHOD FOR TREATING INCREASED EYE PRESSURE USING IT
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
IT1271267B (it) * 1994-12-14 1997-05-27 Valle Francesco Della Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
DE19544635A1 (de) * 1995-11-30 1997-06-05 Boehringer Mannheim Gmbh Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19706903A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
AU765670B2 (en) 1998-04-03 2003-09-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Synthetic endogenous cannabinoids analogues and uses thereof
EP1645270B1 (en) * 1998-05-29 2010-04-28 Neurosciences Research Foundation Inc. Control of pain with ANANDAMIDE
US7589220B2 (en) 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
AU5198199A (en) * 1998-08-17 2000-03-06 Senju Pharmaceutical Co., Ltd. Preventives/remedies for glaucoma
AU1833600A (en) * 1998-11-24 2000-06-19 Andreas Goutopoulos Cannabimimetic lipid amides as useful medications
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6974568B2 (en) 2000-05-23 2005-12-13 The Regents Of The University Of California Treatment for cough
NO20006008L (no) * 2000-11-28 2002-05-29 Thia Medica As Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
JP2004526745A (ja) 2001-03-27 2004-09-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 体脂肪を減らし脂肪酸の代謝を変調する方法、化合物および組成物
WO2003008632A1 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Fatty acid conjugation as a method for screening of potentially bioactive substances
CA2478338A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
JP2006517194A (ja) 2002-06-06 2006-07-20 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム 骨成長を調節するための方法、組成物および製造物
ITMI20030210A1 (it) * 2003-02-07 2004-08-08 Res & Innovation Soc Coop A R L Composti endocannabinoido-simili e loro impiego
US7276608B2 (en) 2003-07-11 2007-10-02 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives as cannabinoid receptor modulators
US7326706B2 (en) 2003-08-15 2008-02-05 Bristol-Myers Squibb Company Pyrazine modulators of cannabinoid receptors
IL160420A0 (en) 2004-02-16 2004-07-25 Yissum Res Dev Co Treating or preventing diabetes with cannabidiol
JP2009538827A (ja) * 2006-05-01 2009-11-12 イースタン バージニア メディカル スクール カンナビノイドおよび使用方法
US20080175902A1 (en) * 2006-11-30 2008-07-24 University Of Plymouth Methods for slowing the progression of multiple sclerosis
WO2009018389A1 (en) 2007-07-30 2009-02-05 Alltranz Inc. Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
WO2009109973A2 (en) * 2008-03-04 2009-09-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compounds and methods of treating obesity
WO2010013240A1 (en) 2008-07-31 2010-02-04 Dekel Pharmaceuticals Ltd. Compositions and methods for treating inflammatory disorders
JP5796909B2 (ja) * 2009-11-25 2015-10-21 サイトメティックス、インコーポレイテッド アラキドン酸類縁体、及びそれによる鎮痛治療
CN103877100B (zh) * 2013-05-21 2016-08-10 成都旗美健康食品有限公司 亚麻酸酰基乙醇胺的联合医用和保健用药物
AU2020260090C9 (en) * 2019-04-15 2023-08-31 Metagenics LLC Novel hemp and PEA formulation and its use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE306730B (zh) * 1963-02-06 1968-12-09 Sumitomo Chemical Co
SE353319B (zh) * 1964-08-15 1973-01-29 Sumitomo Chemical Co
US4619938A (en) * 1984-03-21 1986-10-28 Terumo Kabushiki Kaisha Fatty acid derivatives of aminoalkyl nicotinic acid esters and platelet aggregation inhibitors
NZ216751A (en) * 1985-07-05 1990-01-29 Cird Eicosatriynoic acid esters and amides,pharmaceutical compositions and process for preparing eicosatriynoic acid

Also Published As

Publication number Publication date
AU5733494A (en) 1994-06-22
WO1994012466A1 (en) 1994-06-09
PL309051A1 (en) 1995-09-18
JPH08504195A (ja) 1996-05-07
DE69328492D1 (de) 2000-05-31
CN1097735A (zh) 1995-01-25
ZA938947B (en) 1994-08-02
EP0670826A4 (en) 1996-08-14
ES2145118T3 (es) 2000-07-01
HUT73177A (en) 1996-06-28
SK70895A3 (en) 1995-09-13
EP0670826B1 (en) 2000-04-26
IL103932A0 (en) 1993-04-04
DE69328492T2 (de) 2000-09-07
CZ136195A3 (en) 1995-11-15
EP0670826A1 (en) 1995-09-13
HU9501561D0 (en) 1995-07-28

Similar Documents

Publication Publication Date Title
IL103932A (en) Fatty acid and pharmaceutical compositions containing them
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL105220A0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
IL95351A0 (en) 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them
IL100542A0 (en) Steroid esters and pharmaceutical compositions containing same
ZA908398B (en) Cafeic acid based pharmaceutical and cosmetic depigmenting compositions
IL108019A0 (en) Hydroxyiminoalkylindole-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them
IL99725A0 (en) Saturated hydroxyalkylquinoline acids and pharmaceutical compositions containing them
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
GB2207922B (en) Tripeptides and pharmaceutical compositions containing them
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL105222A0 (en) Cyclohex-1-ene compounds and pharmaceutical compositions containing them
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
IL108073A0 (en) Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them
IL116480A0 (en) Acetic acid deriratives their preparation and pharmaceutical compositions containing them
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
IL105551A0 (en) Quinazolines and pharmaceutical compositions containing them
IL111152A0 (en) Retinoic acid esters, their preparation and pharmaceutical or cosmetic compositions containing them
IL107611A0 (en) Steroid compounds and pharmaceutical compositions containing them
CY1739A (en) Piperazinecarboxylic acid its preparation and pharmaceutical compositions containing it
IL95994A0 (en) Carbamate esters and pharmaceutical compositions containing them
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
IL106214A0 (en) Thf-ypsilon2 analogs and pharmaceutical compositions comprising them
NZ238848A (en) Sulphur-substituted mevinic acid compounds and pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees